A Solution Ahead: Reliable, Customized Solutions For Global Markets

medac CDMO offers end-to-end support for injectable products, covering everything from clinical supply to large-scale commercial manufacturing across its two aseptic sites in Dessau, Germany, and Brno, Czech Republic. The company, founded in 1970, began its CDMO business in 2000 and has since accumulated deep expertise, particularly in isolator-based sterile manufacturing and aseptic fill/finish for complex formulations, including high-potent and non-potent injectables.

The service portfolio includes production of small and large molecule drugs, biologics like ADCs, and oligonucleotides, available in liquid (aseptically filled or terminally sterilized) and freeze-dried formulations. Dosage forms encompass nested pre-filled syringes, nested cartridges, and vials, with scalable batch sizes up to 11,000 liters in campaign. Specialized niche technologies include HPAPI handling (OEB 3 to OEB 6), organic solvent processing, and handling of sensitive products using features like temperature control and nitrogen application. The company provides global regulatory support, development and clinical solutions, stability studies, and comprehensive analytical/microbiological testing.